Cost-effectiveness of 4CMenB vaccination against gonorrhea: importance of dosing schedule, vaccine sentiment, targeting strategy, and duration of protection.
Dariya NikitinLilith K WhittlesJeffrey W Imai-EatonPeter J WhitePublished in: The Journal of infectious diseases (2024)
At UK costs, targeted 4CMenB vaccination of MSM gains QALYs and is cost-saving at any uptake level. Promoting uptake maximizes benefits and is an important role for behavioral science.